HIV Disease Progression to CD4 Count <200 Cells/μL and Death in Saskatoon, Saskatchewan
OBJECTIVE: To characterize and identify determinants of HIV disease progression among a predominantly injection drug use (IDU) HIV population in the highly active antiretroviral therapy era.
Saved in:
Main Authors: | Stephanie Konrad, Stuart Skinner, Germain Bukassa Kazadi, Kali Gartner, Hyun June Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2013/780852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioactive Components and Health Benefits of Saskatoon Berry
by: Lunan Zhao, et al.
Published: (2020-01-01) -
CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells <200 Cell/μL: The DART Trial STI Substudy
by: Jennifer Serwanga, et al.
Published: (2011-01-01) -
Respiratory Medicine in Saskatchewan: An Historical Perspective
by: Donald W Cockcroft
Published: (2015-01-01) -
Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
by: Abigayle Sullivan, et al.
Published: (2020-01-01) -
The Cost of Health Care for AIDS Patients in Saskatchewan
by: Kevin P Browne, et al.
Published: (1990-01-01)